20 April 2025

Last updated: Wednesday 16 April 2025

Policy & Regulation

The EU Clinical Trials Regulation: Legislators see light at the end of the tunnel

Debate heats up over access to clinical trial data

The Special Protocol Assessment: Regulatory success is not guaranteed

The stakes for biopharma from German drug policy

The EU Clinical Trials Directive - Debate over new legislation reaches final stage

The EU Transparency Directive: Further debate on market access

Value-based drug pricing coming soon in UK

Managers ignore pharmacovigilance at their peril

Adaptive licensing: A new approach for drug approvals

IMI: As Big Pharma pulls back, IMI steps in